Evidence map›Paper›PMID 25060891›Full record

ArticleDiabetes2014

Metformin pharmacogenomics: biomarkers to mechanisms.

Liewei Wang, Richard Weinshilboum

Registry-linked trialAbstract readComment
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03445702 (Metformin Gastrointestinal Intolerance), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03445702 early_phase1completedstarted 2018, after this paper: background citation

Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I

Ran2018Enrolled15Registered outcomes2Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Metformin Adverse ReactionArmsMetformin, Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.Reviews of physiology, biochemistry and pharmacology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Liewei WangDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN.
Richard WeinshilboumDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN weinshilboum.richard@mayo.edu.

Funding

Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
INHERITED VARIATIONS IN DRUG-METABOLIZING ENZYMESR01GM028157 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 1985 to 2019
$6.9M
Pharmacogenomics of Breast Cancer Adjuvant ChemotherapyU01HG005137 · NHGRI · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2009 to 2011
$2.1M
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemiaR01CA132780 · NCI · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2008 to 2013
$1.6M
Pharmacogenomics and Mechanisms of Cytidine AnaloguesR01CA138461 · NCI · MAYO CLINIC ROCHESTER · PI WANG, LIEWEI · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA132780NCI NIH HHS R01-CA-132780NCI NIH HHS R01-CA-138461NHGRI NIH HHS U01-HG-05137NIGMS NIH HHS R01-GM-28157NIGMS NIH HHS U19-GM-61388
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PharmacogeneticsDiabetes Mellitus, Type 2HumansHypoglycemic AgentsMetforminHypoglycemic AgentsMetformin

Identifiers

PMID25060891
PMCPMC4113071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.